Showing results (81-90 of 128) with videos related to
Sort By:
Pageof 13
The New England Journal of Medicine|March 28, 2014
Ceritinib in ALK-rearranged non-small-cell lung cancerAlice T Shaw, Dong-Wan Kim, Ranee Mehra, et al.Cancer Discovery|June 14, 2025
Phase Ib basket expansion trial and alternative-schedule dose-escalation study of ATR inhibitor elimusertib in advanced solid tumors with DNA damage response defectsTimothy A Yap, David S P Tan, Anastasios Stathis, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 28, 2016
The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation-Positive Non-Small Cell Lung Cancer: Status in 2016Daniel S W Tan, Sue S Yom, Ming S Tsao, et al.Cancer|September 28, 2023
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomasShivaani Kummar, Lin Shen, David S Hong, et al.Genome Medicine|September 24, 2015
Mutational landscapes of tongue carcinoma reveal recurrent mutations in genes of therapeutic and prognostic relevanceAndre Luiz Vettore, Kalpana Ramnarayanan, Gregory Poore, et al.Lancet (London, England)|January 28, 2017
First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 studyJean-Charles Soria, Daniel S W Tan, Rita Chiari, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2023
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 TrialDaniel S W Tan, Enriqueta Felip, Gilberto de Castro, et al.Oncotarget|November 8, 2017
A three gene immunohistochemical panel serves as an adjunct to clinical staging of patients with head and neck cancerChin-Ann J Ong, Nicholas B Shannon, Stefan Mueller, et al.Nature Medicine|September 19, 2017
Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinomaDaniel S W Tan, Fui Teen Chong, Hui Sun Leong, et al.Lung Cancer (Amsterdam, Netherlands)|January 12, 2025
Asian Thoracic Oncology Research Group expert consensus statement on the peri-operative management of non-small cell lung cancerStephanie P L Saw, Wen-Zhao Zhong, Rui Fu, et al.Pageof 13